Crystal Market Research has released its latest research-based report entitled “Hormonal Contraceptive” market. The report provides a holistic approach to the market growth with a detailed and precise analysis of the overall competitive scenario of the “Hormonal Contraceptive” market global along with the key trends and latest technologies, playing a prominent role in the Hormonal Contraceptive market growth over the next five years.

The Hormonal Contraceptive Market was worth USD 13.24 billion in 2014 and is expected to reach approximately USD 15.60 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 1.84% during the forecast period.

Browse complete report: https://www.crystalmarketresearch.com/report/hormonal-contraceptive-market .

Industry Outlook and Trend Analysis
Increasing awareness with respect to contraception techniques in rising countries, expanding investments by market players to create inventive devices, and strong government activities to enhance access are key patterns quickening market growth. Awareness programs by governments and market players enable boost the demand, and in this manner, market for contraceptives. The advent of long-acting reversible devices in the market is one of the significant driving variables.

Competitive Insights
The major players in the market are Merck & Co, Pfizer, Bayer, Allergan, Teva Pharmaceutical Industries, Agile Therapeutics, Apothecus Inc. and Afaxys. Commercialization and approval of different products and growing geographical presence are real techniques implemented by industry members to improve their share of the overall industry.

Method Outlook and Trend Analysis
In 2016, contraceptive pills represented the biggest share of the market. It is evaluated to keep up its strength all through the estimate time frame. The development of the portion can be ascribed to simple and straightforward method of organization, easy accessibility of a wide range, high awareness about pills because of early market entry in comparison with long-acting devices, and high productivity of around 99% on convenient consumption.

Regional Outlook and Trend Analysis
North America commanded the worldwide hormonal prophylactic market in 2016. The locale is foreseen to hold its situation all through the gauge time frame. This can be credited to high per capita income, rising awareness about sexual health, strong presence of key market players, and substantial number of unintended pregnancies. Asia Pacific is anticipated to witness the speediest development amid the conjecture time frame. Advent of new female contraception devices, vast fertile population, rise in investment by leading players, and solid financial development are the central point supplementing the development of the area.

Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Sample copy of this report: https://www.crystalmarketresearch.com/report-sample/HC04682 .

Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1.Secondary Research
1.2.2.Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
….
7. Company Profiles
7.1.Allergan
7.1.1.Business Overview
7.1.2.Product Portfolio
7.1.3.Strategic Developments
7.1.4.Sales, Revenue and Market Share
7.2. Bayer AG
7.2.1.Business Overview
7.2.2.Product Portfolio
7.2.3.Strategic Developments
7.2.4.Sales, Revenue and Market Share
7.3. Merck & Co., Inc.
7.3.1.Business Overview
7.3.2.Product Portfolio
7.3.3.Strategic Developments
7.3.4.Sales, Revenue and Market Share
7.4. Pfizer
7.4.1.Business Overview
7.4.2.Product Portfolio
7.4.3.Strategic Developments
7.4.4.Sales, Revenue and Market Share
7.5. Afaxys, Inc.
7.5.1.Business Overview
7.5.2.Product Portfolio
7.5.3.Strategic Developments
7.5.4.Sales, Revenue and Market Share
7.6. Teva Pharmaceutical Industries Ltd
7.6.1.Business Overview
7.6.2.Product Portfolio
7.6.3.Strategic Developments
7.6.4.Sales, Revenue and Market Share
7.7.Agile Therapeutics
7.7.1.Business Overview
7.7.2.Product Portfolio
7.7.3.Strategic Developments
7.7.4.Sales, Revenue and Market Share
7.8. Apothecus Pharmaceutical Corp.
7.8.1.Business Overview
7.8.2.Product Portfolio
7.8.3.Strategic Developments
7.8.4.Sales, Revenue and Market Share
8. Global Hormonal Contraceptive Market Competition, by Manufacturer
8.1. Global Hormonal Contraceptive Sales and Market Share by Manufacturer (2016-2017)
8.2. Global Hormonal Contraceptive Revenue and Market Share by Manufacturer (2016-2017)
8.3. Global Hormonal Contraceptive Price by Manufacturer (2016-2017)
8.4. Top 5 Hormonal Contraceptive Manufacturer Market Share
8.5. Market Competition Trend
9. Hormonal Contraceptive Market Forecast (2018-2023)
…

Enquiry before buying: https://www.crystalmarketresearch.com/send-an-enquiry/HC04682 .

Continued…

About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: [email protected]